NCT05102630

Brief Summary

Mechanical ventilation is likely lifesaving in patients with coronavirus disease 2019 (COVID-19) but may also result in adverse events. Only few studies describe the strategies used and adverse effect of mechanical ventilation in an unselected population of ICU patients with COVID-19. This study is designed to be a retrospective study focusing on all mechanical ventilated ICU patients with COVID-19 included in the national Danish COVID ICU database between 10.03.2020 - 02.04.2021 i.e. a total of 1,193 patients. The investigators will register the use of the core interventions around mechanical ventilation and its potential adverse event, including barotrauma and prolonged ventilation. This study will provide important data on the ventilation strategies used and its potential adverse events in unselected ICU patients with COVID-19 and thereby inform clinicians, patients, policy-makers, and future research in this area.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,193

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2021

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 29, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 1, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

November 11, 2021

Status Verified

November 1, 2021

Enrollment Period

8 months

First QC Date

October 29, 2021

Last Update Submit

November 3, 2021

Conditions

Keywords

ARDSMechanical VentilationCOVID-19

Outcome Measures

Primary Outcomes (1)

  • Ventilator days with lung -protective ventilation in percent of all ventilation days with 95%-CI.

    Low tidal volume ventilation (Vt 4-8 mL/kg of predicted body weight)

    Until 90 days

Secondary Outcomes (10)

  • Pneumothorax

    Until 90 days

  • Ventilator days

    Until 90 days

  • Number of patients with prolonged ventilation

    Until 90 days

  • paO2/FiO2 ratio on days of ventilation

    Until 90 days

  • The use of APRV

    Until 90 days

  • +5 more secondary outcomes

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All mechanical ventilated patients registered in the national Danish COVID ICU database

You may qualify if:

  • All mechanical ventilated patients registered in the national Danish COVID ICU database between 10.03.2020 - 02.04.2021 i.e.
  • Admitted to an ICU in Denmark
  • Laboratory-confirmed SARS-CoV-2 infection
  • Use of invasive mechanical ventilation (ventilation via a cuffed endotracheal tube) at any time during the ICU stay

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Anaesthesiology and Intensive Care Medicine, Aalborg University Hospital

Aalborg, 9000, Denmark

RECRUITING

Department of Anesthesiology and Intensive Care, Kolding Hospital

Kolding, 6000, Denmark

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Anne C Brøchner, MD, PhD

    University of Southern Denmark

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anne C Brøchner, MD, Ph D

CONTACT

Nikolai arnold-larsen, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
90 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph D, associate professor

Study Record Dates

First Submitted

October 29, 2021

First Posted

November 1, 2021

Study Start

June 1, 2021

Primary Completion

February 1, 2022

Study Completion

April 1, 2022

Last Updated

November 11, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations